Skip to main content
. 2020 Jun 30;20:260. doi: 10.1186/s12886-020-01462-5

Fig. 1.

Fig. 1

a Vitreous LCN2 levels in eyes with nondiabetic control group and eyes with PDR. b Vitreous vascular endothelial growth factor (VEGF) level in eyes nondiabetic control group and eyes with PDR. PDR = proliferative diabetic retinopathy. * P < .0001